Skip to content

Clinical trials

Completed Brain Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Status: Completed Country / region: Canada Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20122
20134
20141
20164
20172
20181
20192
20204
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
University of British Columbia3
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.3
Eli Lilly and Company2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
TauRx Therapeutics Ltd2
AbbVie (prior sponsor, Abbott)1
Centre hospitalier de l'Université de Montréal (CHUM)1
Inmune Bio, Inc.1
Microvention-Terumo, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases25
Central Nervous System Diseases19
Nervous System Diseases13
Cerebrovascular Disorders7
Neurodegenerative Diseases7
Movement Disorders6
Vascular Diseases6
Brain Ischemia5
Cardiovascular Diseases5
Stroke5

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.